C
LIVE

Serial Number

79265466

Owner

CARSGEN THERAPEUTICS CO., LTD.

Attorney

Adam Bell

Filing Date

Jan 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

C Trademark

Serial Number: 79265466 • Registration: 6087765

C is a trademark filed by CARSGEN THERAPEUTICS CO., LTD. on January 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CARSGEN THERAPEUTICS CO., LTD. (5 trademarks)

Building 12, No.388, Yindu Road,

Entity Type: 03

Trademark Details

Filing Date

January 21, 2019

Registration Date

June 30, 2020

Published for Opposition

April 14, 2020

Goods & Services

Injectable pharmaceuticals for treatment of cancer and autoimmune diseases and disorders; liquid medicine for treatment of cancer and autoimmune diseases and disorders; biological preparations for the treatment of cancer and autoimmune diseases and disorders; drug delivery agents in the form of injections for medical purposes for the treatment of cancer and autoimmune diseases and disorders; vaccine preparations; pharmaceutical preparations for cancer and immunotherapy, in particular for T-cell therapy; blood for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes

Medical apparatus and instruments, namely, sample preparation devices for medical diagnostic use and sample preparation devices for the treatment of cancer and autoimmune diseases and disorders, and apparatus for the regeneration of stem cells for medical purposes; diagnostic apparatus for medical purposes for detecting cancer and autoimmune diseases and disorders; apparatus for use in medical analysis in the fields of cancer and immunology; DNA testing apparatus for medical purposes; surgical apparatus and instruments; medical apparatus and instruments for use in otolaryngology; dental apparatus and instruments, namely, intra-oral light systems; uterine syringes; medical apparatus used in physiotherapy; electrodes for medical use

Filing History

TEAS SECTION 71 & 15 RECEIVED
May 22, 2026 ES75
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 8, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 8, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 8, 2026 REAP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 30, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 14, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 28, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 27, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 30, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 30, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 7, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 7, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 7, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 7, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 27, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 27, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 27, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2020 COAR
REFUSAL PROCESSED BY IB
Oct 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 18, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 18, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 22, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2019 REPR